Trade Names:Cecon- Solution 100 mg/mL
Trade Names:Cevi-Bid- Tablets 500 mg
Trade Names:Chewable Vitamin C- Tablets, chewable 250 mg vitamin C as sodium ascorbate and ascorbic acid- Tablets, chewable 500 mg vitamin C as sodium ascorbate and ascorbic acid
Trade Names:Dull C- Powder 1060 mg/tsp
Trade Names:Fruit C 500- Tablets, chewable 500 mg vitamin C as calcium ascorbate and ascorbic acid
Trade Names:Fruit C 100- Tablets, chewable 100 mg vitamin C as calcium ascorbate and ascorbic acid
Trade Names:Fruit C 200- Tablets, chewable 200 mg vitamin C as calcium ascorbate and ascorbic acid
Trade Names:N'ice Vitamin C Drops- Lozenges 60 mg
Trade Names:Sunkist Vitamin C- Tablets, chewable 60 mg vitamin C as sodium ascorbate and ascorbic acid- Tablets, chewable 250 mg vitamin C as sodium ascorbate and ascorbic acid- Tablets, chewable 500 mg vitamin C as sodium ascorbate and ascorbic acid
Trade Names:Vicks Vitamin C Drops- Lozenges 25 mg vitamin C as sodium ascorbate and ascorbic acid
Trade Names:Vita-C- Crystals 1,000 mg/tspProflavanol (Canada)Revitalose-C-1000 (Canada)Timedose Vitamin C (Canada)
Essential vitamin believed important for synthesis of cellular components, catecholamines, steroids, and carnitine.
Absorbed almost completely from distal small intestine.
Distributed throughout water-soluble compartments. Adrenal cortex, leukocytes, platelets, and pituitary gland contain high concentrations.
Excreted in the urine.
Prevention and treatment of scurvy.
Treatment of idiopathic methemoglobinemia; combination therapy with methenamine to increase acidity of urine. Although not proven scientifically, prevention of common colds and treatment of cancer, asthma, atherosclerosis, burns, and other wounds. Topical vitamin C may photoprotect against UVR because of its antioxidant and anti-inflammatory properties.
PO Recommended daily allowance 60 mg; average protective dose 70 to 150 mg/day.Nicotine useAdults
The RDA for smokers is 100 mg/day because of an increased utilization of vitamin C.High Dose TherapyAdults
Taper vitamin C prior to discontinuing supplementation.ScurvyAdults
IV/IM/subcutaneous 75 to 150 mg/day; up to 6 g/day has been administered without toxicity.Enhanced Wound HealingAdults
PO 300 to 500 mg/day for 7 to 10 days has been given.ParenteralAdults
Used in acute deficiency or when oral absorption is uncertain. Avoid rapid IV administration.
Refrigerate when possible, although storage at room temperature is acceptable.
None well documented.
May cause false-negative results.Urine glucose determinations
May cause false-negative determinations.
Faintness or dizziness may occur with rapid IV administration.
Diarrhea; nausea; vomiting.
Excessive doses over long period of time may cause precipitation of cystine, oxalate or urate crystals in kidney.
Injection site irritation may occur with IM or subcutaneous administration.
Category A . ( Category C in doses above the RDA).
Excreted in breast milk.
Some products contain tartrazine, which can precipitate breathing difficulties in sensitive individuals.
Some products contain sulfites, which may precipitate a reaction in sensitive individuals.
Diabetic patients, patients prone to renal calculi, patients on sodium restricted diets, and those taking anticoagulants should not take excessive doses (more than 5 g/day) over extended periods of time.
Copyright © 2009 Wolters Kluwer Health.